Medical Condition News

RSS

Research could pave way for treatments to reduce risk of heart disease and stroke

The discovery of a previously unknown interaction between proteins could provide a breakthrough in the prevention of damage to healthy blood vessels.

7 Feb 2018

First drug-candidate compounds discovered using AI licensed for development

Insilico Medicine, Inc., a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, announces that Juvenescence.AI, its joint venture with Juvenescence Limited, has licensed its first compound family for clinical development.

7 Feb 2018

New position statement for use of biosimilars to treat rheumatic diseases

Products that are "biosimilar" or interchangeable with a licensed biological product hold considerable promise for the treatment of a variety of medical conditions such as rheumatic diseases, and possibly at a reduced cost.

7 Feb 2018

Researchers discover molecule that enhances cartilage regeneration and curbs inflammation

Will there come a time when a patient with arthritis can forgo joint replacement surgery in favor of a shot? Keck School of Medicine of USC scientist Denis Evseenko, MD, PhD, has reason to be optimistic.

7 Feb 2018

Scientists find new way to kill liver cancer cells

Scientists at the University of Delaware and the University of Illinois at Chicago have found a new way to kill liver cancer cells and inhibit tumor growth. First, they silence a key cellular enzyme, and then they add a powerful drug.

7 Feb 2018

New discovery could be key to stopping damage caused by inflammation in many diseases

A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer's and gout.

7 Feb 2018

USC scientists uncover cellular mechanism responsible for ALS and frontotemporal dementia

Scientists have for the first time discovered a mechanism that limits the number of "cellular janitors" in the nervous system, leading to increased risk for two neurodegenerative diseases: amyotrophic lateral sclerosis and frontotemporal dementia, according to a Keck School of Medicine of USC study published today in Nature Medicine.

7 Feb 2018

Many epilepsy patients receive interacting drug combinations

In an Epilepsia analysis of 2008-2010 Medicare claims data, one in four older Americans with new-onset epilepsy and more than one-third with prevalent epilepsy received a combination of antiepileptic drugs and non-epilepsy drugs that could interact to alter the effectiveness of the non-epilepsy drugs.

7 Feb 2018

Altered immune cell clocks may contribute to metabolic diseases in shift workers

About 15 million Americans don't have a typical nine-to-five workday, and many of these--nurses, firefighters and flight attendants, among many other professions--may see their schedule change drastically one week to the next.

7 Feb 2018

Social interaction could enhance dementia care, finds study

Increasing social interaction among people living with dementia in care homes could improve the quality of their life and save money, suggests new study.

7 Feb 2018

Yoga training offers benefits to adults with metabolic syndrome

In a recent Scandinavian Journal of Medicine & Science in Sports study, one year of yoga training decreased pro-inflammatory adipokines and increased an anti-inflammatory adipokine in adults with metabolic syndrome and high-normal blood pressure.

7 Feb 2018

Loss of coenzyme Q10 increases pre-diabetes risk

Levels of CoQ and the presence of insulin resistance were analyzed in a range of experimental laboratory settings, mouse models and samples from humans, as part of an ambitious research collaboration conducted with the University of Sydney, Victor Chang Cardiac Research Institute, Duke University School of Medicine, Garvan Institute of Medical Research, Genentech Inc. and the University of New South Wales.

7 Feb 2018

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

A new partnership in Leeds has been agreed to evaluate the benefits of a diagnostic blood test which can help predict whether someone is likely to develop type 2 diabetes.

7 Feb 2018

Patients with acne have increased risk of developing major depression

In an analysis of one of the largest electronic medical records databases in the world, researchers found that patients with acne had a significantly increased risk of developing major depression, but only in the first 5 years after being diagnosed with acne.

7 Feb 2018

LUNGevity Foundation launches initiative to promote stronger adherence to lung cancer screening

LUNGevity Foundation announced the launch of Project ACTS – Increasing Adherence to CT Screening for lung cancer – a multi-stakeholder project funded by a grant from Bristol-Myers Squibb Foundation through their Bridging Cancer Care initiative.

7 Feb 2018

Study adds more evidence that intestinal microbiome plays substantial role in obesity

A new Johns Hopkins study of mice with the rodent equivalent of metabolic syndrome has added to evidence that the intestinal microbiome - a "garden" of bacterial, viral and fungal genes - plays a substantial role in the development of obesity and insulin resistance in mammals, including humans.

6 Feb 2018

Study shows why insulin secretion does not work properly in type 2 diabetic individuals

In a new study, researchers from the universities of Uppsala and Lund show why insulin secretion is not working properly in patients suffering from type-2 diabetes.

6 Feb 2018

Study tests influence of arm training on post-stroke leg function

A new study shows that arm exercises may improve walking ability months and even years after having a stroke. The study, the first to test the influence of arm training on post-stroke leg function, is published ahead of print in the Journal of Neurophysiology.

6 Feb 2018

Researchers develop novel antibody-based therapy to treat organ fibrosis

Fibrosis can be triggered by many events- surgery, injury, disease- but regardless of the cause, it's characterized by accumulating masses of collagen-packed scar tissue that can permanently damage compromised organs.

6 Feb 2018

Open Pharma drug discovery project aims to develop new treatments for mycetoma

The MycetOS project was launched today by the University of Sydney, Erasmus MC, and the Drugs for Neglected Diseases initiative to use an Open Pharma approach to discover compounds that could lead to new treatments for patients suffering from fungal mycetoma (eumycetoma), a devastating disease for which current treatments are ineffective, expensive, and toxic.

6 Feb 2018

Medical Condition News

Research could pave way for treatments to reduce risk of heart disease and stroke

First drug-candidate compounds discovered using AI licensed for development

New position statement for use of biosimilars to treat rheumatic diseases

Researchers discover molecule that enhances cartilage regeneration and curbs inflammation

Scientists find new way to kill liver cancer cells

New discovery could be key to stopping damage caused by inflammation in many diseases

USC scientists uncover cellular mechanism responsible for ALS and frontotemporal dementia

Many epilepsy patients receive interacting drug combinations

Altered immune cell clocks may contribute to metabolic diseases in shift workers

Social interaction could enhance dementia care, finds study

Yoga training offers benefits to adults with metabolic syndrome

Loss of coenzyme Q10 increases pre-diabetes risk

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

Patients with acne have increased risk of developing major depression

LUNGevity Foundation launches initiative to promote stronger adherence to lung cancer screening

Study adds more evidence that intestinal microbiome plays substantial role in obesity

Study shows why insulin secretion does not work properly in type 2 diabetic individuals

Study tests influence of arm training on post-stroke leg function

Researchers develop novel antibody-based therapy to treat organ fibrosis

Open Pharma drug discovery project aims to develop new treatments for mycetoma

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News